Opko Health Inc (OPK)
OPKO Health, Inc. is a healthcare company listed on NASDAQ as common stock under the symbol OPK. The company operates internationally, with activities in the United States, Ireland, Chile, Spain, Israel, Mexico, and other markets. Its business is organized into two segments: Pharmaceutical and Diagnostics. The Pharmaceutical segment focuses on developing and commercializing candidates and products including MDX2001, MDX2003, and MDX2004, along with an Epstein Barr Virus vaccine program, Rayaldee, OPK-88006, and NGENLA. The Diagnostics segment provides laboratory testing and related services through the BioReference brand, covering areas such as disease detection, diagnosis, monitoring, molecular diagnostics, anatomical pathology, genetics, women’s health, correctional healthcare, and the 4Kscore test. Founded in 2006, OPKO Health is headquartered in Miami, Florida.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-OPK
|
$1.36
|
-21.5% Downside
|
Overvalued
|
$4.38
|
152.9% Upside
|
Bargain
|
Good
|
0.0%
|
November 11, 2026
|
1.1x
|
2.2x
|
1.291 B
|
1.348 B
|
24.0%
|
43.4%
|
-3.0
|
183.9%
|
